# Sphingolipid Synthesis > Sphingolipid synthesis in MBBS Biochemistry: serine palmitoyltransferase, ceramide hub, sphingomyelin, glycosphingolipids, gangliosides and storage diseases. - Canonical URL: https://prepelephant.com/topics/mbbs/biochemistry/sphingolipid-synthesis - Exam / course: MBBS · Subject: Biochemistry - Publisher: PrepElephant (https://prepelephant.com) — Prepared and reviewed by the PrepElephant Academic Review Team - First published: 2026-10-02 - Last updated: 2026-10-02 - How to cite: "Sphingolipid Synthesis", PrepElephant, https://prepelephant.com/topics/mbbs/biochemistry/sphingolipid-synthesis ## Direct answer Palmitoyl-CoA plus serine: that condensation, catalysed by serine palmitoyltransferase, opens every sphingolipid pathway in the cell. The product 3-ketosphinganine reduces to sphinganine, gains an acyl chain as dihydroceramide, and desaturates to ceramide — the hub of the family. From ceramide, phosphocholine donated by phosphatidylcholine builds sphingomyelin (the only phosphorus-containing sphingolipid), while UDP-glucose or UDP-galactose start glycosphingolipids: cerebrosides, globosides and, once sialic acid is appended, gangliosides concentrated in neural membranes. Each branch degrades through a specific lysosomal hydrolase, and each missing hydrolase produces a named sphingolipidosis — the synthesis map's clinical mirror image. ## What you must remember - **Rate-limiting enzyme:** serine palmitoyltransferase, inhibited by myriocin — the standard research tool and an occasional viva fact. - **Hub metabolite:** ceramide, built on a sphingosine (C18 amino alcohol) backbone — the entire family is glycerol-free, unlike glycerophospholipids. - **Sphingomyelin synthase:** transfers phosphocholine (not choline alone) from phosphatidylcholine to ceramide in the Golgi; sphingomyelin is myelin's major non-glycerol phospholipid. - **Glycosphingolipid ladder:** galactosylceramide in myelin, glucosylceramide as the precursor of globosides and gangliosides; gangliosides carry one or more N-acetylneuraminic (sialic) acid residues — GM1, GM2 nomenclature. - **Storage-disease pairing:** Gaucher (glucocerebrosidase; crumpled-tissue-paper macrophages), Krabbe (galactocerebrosidase), Niemann-Pick A/B (acid sphingomyelinase; cherry-red spot, foam cells), Tay-Sachs (hexosaminidase A; GM2, startle response), Sandhoff (hexosaminidase A and B), Farber (ceramidase; painful joints, hoarseness). - **The inheritance exception:** Fabry disease (alpha-galactosidase A) is X-linked recessive — every other classic sphingolipidosis is autosomal recessive; the exam's trick question. - **Signalling roles:** ceramide drives apoptosis, sphingosine-1-phosphate promotes survival and egress — the "sphingolipid rheostat" concept. - **Therapy anchors:** enzyme replacement with imiglucerase for Gaucher; substrate reduction with miglustat inhibits glucosylceramide synthase, the first glycosylation step. ## Working through a Tay-Sachs case A nine-month-old of unaffected parents loses milestones and startles violently at sound. The examination finds a cherry-red macula; fundus first, biochemistry second. Hexosaminidase A assay in leucocytes shows near-absent activity with normal total hexosaminidase — because hexosaminidase B is intact, the pattern that separates Tay-Sachs from Sandhoff disease, where both A and B fall and visceral storage (liver, spleen) joins the picture. GM2 accumulates because the ganglioside's terminal N-acetylgalactosamine cannot be cleaved. GM2 activator protein deficiency mimics the same chemistry with normal enzyme activity — a research-level refinement that occasionally surfaces in postgraduate vivas. Genetic counselling follows autosomal-recessive logic; carrier screening by enzyme assay predates DNA testing and is still used in high-risk communities. The synthesis-pathway lesson: the disease maps one step of degradation for one branch of the ceramide family tree. ## Where students slip The recurring slips are structural and genetic. "Sphingomyelin contains phosphate" — yes, and it is the only sphingolipid that does; glycosphingolipids contain none, and that single distinction answers several MCQs. Fabry's X-linked inheritance is forgotten under pressure, wrecking a pedigree question. Students also invert the enzyme-substrate pairs of Gaucher versus Krabbe — anchor them by the myelin logic: galactosyl cerebroside dominates myelin, so galactocerebrosidase deficiency (Krabbe) is a white-matter disease of infants, while glucosylceramide accumulates in macrophages of marrow and spleen in Gaucher, producing hepatosplenomegaly with the characteristic crumpled-tissue-paper cytoplasm on smear. Finally, remember that lysosomal degradation requires saposin activator proteins; their deficiency produces storage phenotypes despite intact hydrolases. ## Frequently asked questions ### Which enzyme catalyses the committed step of sphingolipid synthesis? Serine palmitoyltransferase, condensing palmitoyl-CoA with serine; myriocin specifically inhibits it. ### Which sphingolipid contains phosphorus? Sphingomyelin alone, carrying a phosphocholine head group donated by phosphatidylcholine. ### Which enzyme is deficient in Gaucher disease? Lysosomal acid beta-glucocerebrosidase, so glucosylceramide accumulates in macrophages, which display the crumpled-tissue-paper appearance. ### How does Tay-Sachs differ from Sandhoff disease? Tay-Sachs lacks hexosaminidase A only, while Sandhoff lacks both A and B components, adding visceral organomegaly to the GM2 neurodegeneration. ### What is the ceramide-sphingosine-1-phosphate rheostat? A balance concept: ceramide and sphingosine push the cell toward apoptosis, while sphingosine-1-phosphate signals survival and proliferation.